Anhui Anke Biotechnology (Group) Co (SZSE:300009) Total Liabilities : ¥835 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Total Liabilities?

Anhui Anke Biotechnology (Group) Co's Total Liabilities for the quarter that ended in Dec. 2024 was ¥835 Mil.

Anhui Anke Biotechnology (Group) Co's quarterly Total Liabilities declined from Jun. 2024 (¥894.37 Mil) to Sep. 2024 (¥858.57 Mil) and declined from Sep. 2024 (¥858.57 Mil) to Dec. 2024 (¥835.41 Mil).

Anhui Anke Biotechnology (Group) Co's annual Total Liabilities increased from Dec. 2022 (¥855.17 Mil) to Dec. 2023 (¥1,018.43 Mil) but then declined from Dec. 2023 (¥1,018.43 Mil) to Dec. 2024 (¥835.41 Mil).

Anhui Anke Biotechnology (Group) Co Total Liabilities Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Total Liabilities Chart

Anhui Anke Biotechnology (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

600.29

765.52

855.17

1,018.43

835.41

Anhui Anke Biotechnology (Group) Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															1,018.43	960.81	894.37	858.57	835.41

Anhui Anke Biotechnology (Group) Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Anhui Anke Biotechnology (Group) Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	667.585	+	(38.247	+	129.58
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	835

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	5135.35	-	4299.938
	=	835

Anhui Anke Biotechnology (Group) Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	667.585	+	(38.247	+	129.58
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	835

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	5135.35	-	4299.938
	=	835

Anhui Anke Biotechnology (Group) Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Anke Biotechnology (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088

Website

http://www.ankebio.com

Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.

Executives

Zhao Hui	Directors, executives
Zhou Yuan Yuan	Directors, executives
Wang Yong	Supervisors
Yao Jian Ping	Executives
Wang Rong Hai	Directors, executives
Song She Wu	Directors, executives
Fu Yong Biao	Directors, executives
Jiang Jun Pei	Supervisors
Xu Zhen Shan	Director
Lu Guang Xin	Executives
Yan Xin Wen	Executives
Lu Chun Yan	Executives
Wu Rui	Director
Fan Qing Lin	Director
Wang Yong Bin	Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines